Generics 67

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dexchlorpheniramine maleate manufacturers

67 products found

Filters

67 products found

dexchlorpheniramine maleate

Tablets 2 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Australia , New Zealand
Registered in
Australia
Available for
Licensing with supply
Comments
Interested in projects only for European markets.
Manufacturer #15224

Manufacturer usually replies in 7 days

dexchlorpheniramine maleate

Capsules 6 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #21682

Manufacturer usually replies in 1 days

dexchlorpheniramine maleate

Tablets 6 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #21682

Manufacturer usually replies in 1 days

dexchlorpheniramine maleate

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
Malaysia
Manufacturer #21006

Manufacturer usually replies in 2 days

dexchlorpheniramine maleate

Syrup 1 mg, 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
Malaysia
Manufacturer #21006

Manufacturer usually replies in 2 days

dexchlorpheniramine maleate

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19472

Manufacturer usually replies in 4 days

dexchlorpheniramine maleate

Oral solution 0.4 mg / mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18982
It has been in the drug market for more than 20 years. The company has become a solid and efficient company, investing in research, innovation, qualified labor, and state-of-the-art equipment. Its portfolio currently comprises more than 60 drugs.

Manufacturer usually replies in 3 days

dexchlorpheniramine maleate + pseudoephedrine sulfate + guaifenesin

Oral solution 0.4 mg + 4 mg + 20 mg / ml - 120 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #18979
The company has stood out in the national pharmaceutical market and is currently among the top 20 laboratories in the ranking, according to the IMS. The mission expresses the commitment to working towards health and meeting the needs of the population, ethically, seeking to gain more and more the trust of doctors and consumers. Its distribution network of medicines MIP (medicines without prescription) is present throughout the national territory and the activity of propagation of medicines with the medical class expands gradually, reaching today 24 states of the federation.

Manufacturer usually replies in 3 days

dexchlorpheniramine maleate

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18411

Manufacturer usually replies in 2 days

dexchlorpheniramine maleate

Oral solution 2 mg/5 ml - 100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #16236
With the mission of "For a Healthy Tomorrow," it has been creating products for over 35 years to contribute to human health. They understand what it takes to run a manufacturing facility where GMP requirements are strictly followed and product, environmental, and employee safety are prioritized. With 140+ goods, over 21,000 square meters of indoor area, and a production capacity of over 142 million boxes each year.

Manufacturer usually replies in 7 days

dexchlorpheniramine maleate

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20982

Manufacturer usually replies in 9 days

dexchlorpheniramine maleate

Syrup 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
Malaysia
Manufacturer #20939
It was incorporated in the 1980s as a small-scale manufacturer of generic pharmaceuticals. Following the implementation of GMP requirements by the Ministry of Health and the expansion of the business operations. They also provide OEM facilities with the same stringent standards of quality and acceptability that apply to their home-brand products.

Manufacturer usually replies in 8 days

dexchlorpheniramine maleate

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Malaysia
GMP approvals
Malaysia
Manufacturer #20939
It was incorporated in the 1980s as a small-scale manufacturer of generic pharmaceuticals. Following the implementation of GMP requirements by the Ministry of Health and the expansion of the business operations. They also provide OEM facilities with the same stringent standards of quality and acceptability that apply to their home-brand products.

Manufacturer usually replies in 8 days

dexchlorpheniramine maleate

Syrup 0.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, Yemen, Iraq
Manufacturer #20752
It is a pharmaceutical manufacturing company that was founded in Palestine 50 years ago. As an industry pioneer, it sought to address the shortages in medicinal products’ supplies as well as the untapped pharma innovation gap in Palestine. The core business is the development, manufacturing, and marketing of pharmaceutical products. To complement its medicinal products portfolio, the company has recently established partnerships with leading medical device and pharmaceutical manufacturers, thereby strengthening both the portfolios for medical devices and pharmaceutical medicines in Palestine and the region. In addition, they also produce detergent, cosmetics, personal hygiene, veterinary and agricultural products.

Manufacturer usually replies in 6 days

dexchlorpheniramine maleate

Tablets 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, Yemen, Iraq
Manufacturer #20752
It is a pharmaceutical manufacturing company that was founded in Palestine 50 years ago. As an industry pioneer, it sought to address the shortages in medicinal products’ supplies as well as the untapped pharma innovation gap in Palestine. The core business is the development, manufacturing, and marketing of pharmaceutical products. To complement its medicinal products portfolio, the company has recently established partnerships with leading medical device and pharmaceutical manufacturers, thereby strengthening both the portfolios for medical devices and pharmaceutical medicines in Palestine and the region. In addition, they also produce detergent, cosmetics, personal hygiene, veterinary and agricultural products.

Manufacturer usually replies in 6 days

dexchlorpheniramine maleate

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20504
The company was formed in the 1970s. The company has been holding more than 200 licenses including sugar coating tablets, film coating tablets, enteric coating tablets, granule, powder, capsule, solution, cream, ointment, and suppositories.

Manufacturer usually replies in 10 days

dexchlorpheniramine maleate

Tablets 2 mg, 4 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

dexchlorpheniramine maleate

Syrup 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

dexchlorpheniramine maleate + guaifenesin + pseudoephedrine

Syrup 2 mg + 10 mg + 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

dexchlorpheniramine maleate

Tablets, sustained release (SR) 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20224

Manufacturer usually replies in 9 days

Want to view all 67 products? Create your free account today!

Dexchlorpheniramine Maleate

Dexchlorpheniramine Maleate is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. These symptoms are rashes, watery eyes, itchy eyes or nose or throat or skin, cough, sneezing, and a runny nose. Dexchlorpheniramine Maleate is an antagonist of the histamine H1 receptor with anticholinergic properties and is a dextrorotatory isomer of chlorpheniramine. It is the S- the enantiomer of chlorpheniramine which is a 1st generation anti-histamine. Dexchlorpheniramine has a wider range of pharmacological uses than others and is far more potent than the racemic mixture. Dexchlorpheniramine treats seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticarial, dermographism, angioedema, amelioration of allergic reactions to plasma or blood. Dexchlorpheniramine Maleate is traded under the name Ryclora amongst others. Merck Sharp and Dohme Corp patented it first in 1962 and came into medical use in 1969.

Dosage and administration

Dexchlorpheniramine Maleate is available as an Oral Solution. It is sold as a red-colored, cherry-flavored liquid in 4 fl oz or 118 mL and 16 fl oz or 473 mL sizes. Dexchlorpheniramine Maleate dosage should be set as the needs of the patient. The recommended dose for Adults and Children 12 years of age and older is 2 mg or one teaspoonful, for Children between 6 to 11 years, the dose is set at 1 mg or half a teaspoonful and for children between 2 to 5 years, the dose is set at 0.5 mg or one-fourth of a teaspoonful. The general time interval between the doses is 4 to 6 hours.

The cost of DEXCHLORPHENIRAMINE MALEATE

In the USA, the consumer has to pay an average price of around $886.99 for 118ML of 2MG/5ML Bottle. This medicine is significantly cheaper in the developing and underdeveloped world. Consumers in India have to pay only around USD3.5 for 200 tablets.

How does DEXCHLORPHENIRAMINE MALEATE work?

Dexchlorpheniramine Maleate blocks histamine, made by the body during an allergic reaction. It also blocks Acetylcholine. This results in relieving the symptoms of allergy like watery eyes and runny nose. During a reaction, the allergen binds itself to the IgE antibodies on mast cells and basophils. The result of biding is that the IgE receptors crosslink with each other. This initiates events that eventually result in cell-degranulation and in the process, gets rid of the histamine inside the mast cell or basophil. Histamine reacts to both local and widespread tissues via its receptors. Histamine produces pruritis, vasodilatation, hypotension, headache, flushing, bronchoconstriction, and tachycardia. It improves vascular permeability and potentiates pain.

Finding DEXCHLORPHENIRAMINE MALEATE Manufacturers and Suppliers:

The process of finding trusted DEXCHLORPHENIRAMINE MALEATE manufacturers and DEXCHLORPHENIRAMINE MALEATE suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is easy to use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of DEXCHLORPHENIRAMINE MALEATE. The search can be further refined with industry- specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. Helping to get in contact with the preferred manufacturer and supplier readily.